CIK 0002019410 · Non-accelerated filer<br>Emerging growth company
Caris Life Sciences, Inc.
Sign in to watch- Ticker
- CAI
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- TX
- Entity type
- operating
- EIN
- 852077369
- Phone
- (866) 771-8946
- Business address
- 750 W JOHN CARPENTER FREEWAY, SUITE 800, IRVING, TX, 75039
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale See Remarks sold 7,500 shares at $31.82 ($238,626)
- 144 Insider Sale of Securities
- 4 Open-market sale See Remarks sold 400,000 shares at $30.33 ($12,132,080)
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure
- 4 Open-market sale President sold 597,212 shares at an average $24.84 ($14,834,107)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Grant or award Director acquired 13,192 shares (grant or award)
- 4 Grant or award Director acquired 13,192 shares (grant or award)
- 4 Grant or award Director acquired 13,192 shares (grant or award)
- 4 Grant or award Director acquired 13,192 shares (grant or award)
- 4 Grant or award Director acquired 13,192 shares (grant or award)
- 4 Grant or award Director acquired 13,192 shares (grant or award)
- 4 Grant or award Director acquired 13,192 shares (grant or award)
- 4 Grant or award Director acquired 13,192 shares (grant or award)
Page 1 of 7 · 134 filings